Alaska Permanent Fund Corp Vir Biotechnology, Inc. Transaction History

Alaska Permanent Fund Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$30.97 - $54.03 $39.4 Million - $68.7 Million	-1,272,438 Reduced 35.62%	2,300,000 $79 Million
Q3 2021 Nov 09, 2021	SELL	$34.9 - $54.54 $7.94 Million - $12.4 Million	-227,562 Reduced 5.99%	3,572,438 $155 Million
Q1 2021 Apr 28, 2021	SELL	$26.34 - $83.07 $26.3 Million - $83.1 Million	-1,000,000 Reduced 20.83%	3,800,000 $195 Million
Q2 2020 Aug 12, 2020	BUY	$27.89 - $47.86 $92 Million - $158 Million	3,300,000 Added 220.0%	4,800,000 $197 Million
Q1 2020 May 05, 2020	BUY	$12.04 - $60.2 $18.1 Million - $90.3 Million	1,500,000 New	1,500,000 $51.4 Million

218

87M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $982M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Alaska Permanent Fund Corp, based on Form 13F filings with the SEC.

Stay updated on Alaska Permanent Fund Corp with notifications on news.